Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMERI.L Regulatory News (MERI)

  • There is currently no data for MERI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

12 Apr 2019 08:45

RNS Number : 0329W
Merian Chrysalis Investment Co. Ltd
12 April 2019
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than the United Kingdom), Canada, Australia, Japan or the Republic of South Africa.

 

12 April 2019

 

For immediate release

 

Merian Chrysalis Investment Company Limited (the "Company")

 

Portfolio Update

 

As announced by the Company on 5 March 2019, the net asset value ("NAV") per ordinary share of the Company was 98.54 pence as at 31 December 2018.

The Company is aware of pricing information attributable to an expected transaction by one of the Company's portfolio investments, which represents a material increase in the value previously assigned by the Company to that investment. The Company is not participating in this transaction. As a result of this expected transaction, the Company estimates an increase of approximately 8.9 pence per ordinary share to the Company's last reported NAV per ordinary share.

The Company's NAV and NAV per ordinary share as at 31 March 2019 will be calculated in accordance with its valuation policy and is expected to be reported in May in accordance with the usual reporting timetables. Shareholders should note that the calculation of the NAV per ordinary share as at 31 March 2019 will also take account of the latest valuations of the Company's other investments (including exchange rate movements in respect of those other investments where applicable) which are not known at this time. As such, this announcement does not constitute or describe an updated NAV of the Company.

This announcement contains inside information.

 

-End-

 

 

For further information, please contact: Merian Global Investors:

Will Gold

 

 

+44 (0) 20 7332 7500

Liberum Capital:

Gillian Martin / Christopher Britton

 

+44 (0) 20 3100 2222

Zeus Capital:

John Goold / Ben Robertson

 

+44 (0) 20 3829 5000

Maitland Administration (Guernsey) Limited:

Aimee Gontier / Elaine Smeja

+44 (0) 1481 749364

 

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at https://www.merian.com/chrysalis/. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUFMGMDNZRGLZG
Date   Source Headline
19th Mar 202012:09 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
18th Mar 20202:51 pmRNSDirector/PDMR Shareholding
13th Mar 20207:00 amRNSNet Asset Value(s)
9th Mar 20204:36 pmRNSPrice Monitoring Extension
28th Feb 20204:05 pmRNSResult of AGM
17th Feb 20203:11 pmRNSCorporate Update
30th Jan 20207:00 amRNSNotice of AGM
24th Jan 20207:00 amRNSFinal Results
15th Jan 20203:46 pmRNSAppointment of Senior Independent Director
15th Jan 20207:00 amRNSPortfolio Update
11th Dec 20197:00 amRNSPortfolio Update
3rd Dec 20197:00 amRNSNet Asset Value(s)
27th Nov 20197:00 amRNSPortfolio Update
23rd Oct 20197:00 amRNSPortfolio Update
1st Oct 20199:21 amRNSHolding(s) in Company
27th Sep 20194:49 pmRNSHolding(s) in Company
27th Sep 20193:47 pmRNSHolding(s) in Company
27th Sep 20193:46 pmRNSHolding(s) in Company
27th Sep 201912:46 pmRNSHolding(s) in Company
27th Sep 20197:00 amRNSHolding(s) in Company
26th Sep 20198:00 amRNSPDMR shareholdings
25th Sep 20193:16 pmRNSHolding(s) in Company
25th Sep 20193:12 pmRNSDirector Declaration
24th Sep 20197:00 amRNSResult of Placing under Placing Programme
20th Sep 20197:00 amRNSPlacing Update
18th Sep 20197:00 amRNSAnnouncement of Placing Price
10th Sep 20197:00 amRNSPlacing under Placing Programme
30th Aug 20197:00 amRNSNet Asset Value(s)
16th Aug 20197:00 amRNSPortfolio Update
6th Aug 20192:20 pmRNSPortfolio Update
4th Jul 20197:00 amRNSPortfolio Update
28th Jun 20196:31 pmRNSHalf-year Report
20th Jun 20197:00 amRNSCorporate Update
31st May 20197:00 amRNSNet Asset Value(s)
7th May 20193:55 pmRNSHolding(s) in Company
26th Apr 20193:36 pmRNSHolding(s) in Company
24th Apr 20191:10 pmRNSHolding(s) in Company
24th Apr 20191:08 pmRNSHolding(s) in Company
24th Apr 20191:06 pmRNSHolding(s) in Company
18th Apr 20194:52 pmRNSDirector/PDMR Shareholding
18th Apr 20191:43 pmRNSHolding(s) in Company
16th Apr 20197:00 amRNSResult of Placing under Placing Programme
15th Apr 20197:00 amRNSPlacing Update
12th Apr 20198:46 amRNSProposed Placing Price
12th Apr 20198:45 amRNSPortfolio Update
26th Mar 20197:00 amRNSPlacing under Placement Programme
5th Mar 20197:00 amRNSNAV Announcement and Portfolio Update
22nd Feb 20191:22 pmRNSStarling Bank awarded CIF Pool A grant
13th Feb 20197:00 amRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.